Stryker Corporation cash flow statement
In fiscal 2025, Stryker Corporation's operations generated $5.04bn of cash; it spent $761m on capital projects, leaving free cash flow of $4.28bn. It returned $1.28bn in dividends.
Cash flow statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,461 | 1,547 | 1,434 | 1,657 | 1,886 | 1,782 | 981 | 1,915 | 1,559 | 2,610 | 2,191 | 3,277 | 3,263 | 2,624 | 3,711 | 4,242 | 5,044 | 5,446 |
| Depreciation and amortisation | 385 | 410 | 481 | 486 | 511 | 586 | 590 | 752 | 859 | 966 | 1,044 | 1,076 | 1,272 | 1,278 | 1,341 | 1,426 | 1,570 | 1,615 |
| Stock-based pay | 62 | 69 | 75 | 75 | 76 | 77 | 86 | 97 | 113 | 119 | 127 | 142 | 171 | 168 | 205 | 229 | 243 | 256 |
| Capital spending | 131 | 182 | 226 | 210 | 195 | 233 | 270 | 490 | 598 | 572 | 649 | 487 | 525 | 588 | 575 | 755 | 761 | 873 |
| Free cash flow | 1,330 | 1,365 | 1,208 | 1,447 | 1,691 | 1,549 | 711 | 1,425 | 961 | 2,038 | 1,542 | 2,790 | 2,738 | 2,036 | 3,136 | 3,487 | 4,283 | 4,573 |
| Free cash flow after stock pay | 1,268 | 1,296 | 1,133 | 1,372 | 1,615 | 1,472 | 625 | 1,328 | 848 | 1,919 | 1,415 | 2,648 | 2,567 | 1,868 | 2,931 | 3,258 | 4,040 | 4,317 |
| Dividends paid | 198 | 238 | 279 | 324 | 401 | 462 | 521 | 568 | 636 | 703 | 778 | 863 | 950 | 1,051 | 1,139 | 1,219 | 1,284 | 1,333 |
| Share buybacks | 0 | 426 | 622 | 108 | 317 | 100 | 700 | 13 | 230 | 300 | 307 | 0 | 0 | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,931 | 250 | 1,111 | 1,540 | 2,143 | 581 | 1,261 | 1,461 |
| Depreciation and amortisation | 346 | 361 | 387 | 402 | 417 | 397 | 404 | 397 |
| Stock-based pay | 45 | 84 | 49 | 62 | 48 | 87 | 54 | 67 |
| Capital spending | 266 | 123 | 183 | 187 | 268 | 166 | 202 | 237 |
| Free cash flow | 1,665 | 127 | 928 | 1,353 | 1,875 | 415 | 1,059 | 1,224 |
| Free cash flow after stock pay | 1,620 | 43 | 879 | 1,291 | 1,827 | 328 | 1,005 | 1,157 |
Compare with peers
- GE HealthCare cash flow
- Boston Scientific cash flow
- Koninklijke Philips NV cash flow
- Medtronic cash flow
- Abbott Laboratories cash flow
Head to head: GEHC vs SYKBSX vs SYKPHG vs SYKMDT vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies